Background
Previous studies have found that many adverse drug events (ADEs) in inpatients can be detected or prevented by alerting physicians to measured physiologic parameters such as an elevated creatinine or hyperkalemia. 1, 2 In developing a decision support system for an outpatient Electronic Medical Record, we have begun to retrospectively study associations between drugs and labs that could trigger an alert to physicians. It is unknown whether such a drug-lab monitoring system is useful in identifying or preventing ADEs in outpatients.
Methods
We developed a list of drug-lab triggers using previously published lists and established contraindications for specific drugs. Lab and dose criteria were set using published data when possible and expert opinion when the data was unavailable. For each trigger, we searched the electronic medical records of outpatient clinics in the Partners Health System between 1/1998 and 2/2001. Only the records of patients who were prescribed the drug of interest and had a documented lab of interest were eligible. For each patient record, we determined if the trigger conditions were met at least once during the study period.
Results
The proportion of eligible patients who satisfied the trigger criteria at least once is reported in Table 1 . Observed frequencies were calculated by dividing the number of patients who fulfilled all lab and dose criteria by the total number of patients prescribed the drug and had the relevant lab recorded. The most frequent association was between a high allopurinol dose and renal insufficiency occurring in 8.9% of patients prescribed allopurinol.
Conclusion
Drug-lab triggers have potential to alert physicians to impending and actual adverse drug events. Events will need to be reviewed in order to calculate a positive predictive value for each trigger. Additionally, confirmation of the utility of triggers will require prospective study of patient outcomes associated with a positive trigger.
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